BioCentury
ARTICLE | Clinical News

Rempex Pharmaceuticals preclinical data

September 17, 2012 7:00 AM UTC

In a nitrocefin degradation assay, which measures the kinetics of beta lactamase activity, RPX7009 inhibited Klebsiella pneumoniae carbapenemase-2 (KPC-2) with a Ki value of 0.071 µM, while clavulanic...